论文部分内容阅读
目的:评价盐酸氨溴索与盐酸丙卡特罗联用对小儿肺炎患者的临床疗效。方法:选取2011年8月—2014年10月收治的小儿肺炎患者108例,将其分为对照组与观察组,每组54例;对照组患者给予常规方法治疗,观察组患者在此基础上给予盐酸氨溴索与盐酸丙卡特罗联用治疗,比较两组患者治疗后的临床疗效。结果:观察组患者治疗后的总有效率为94.44%显著高于对照组为68.52%(P<0.05)。结论:盐酸氨溴索与盐酸丙卡特罗联用治疗小儿肺炎患者的临床疗效优于常规方法治疗,且迅速缓解患者临床症状,改善免疫功能。
Objective: To evaluate the clinical efficacy of ambroxol hydrochloride combined with procaterol hydrochloride in children with pneumonia. Methods: A total of 108 cases of pediatric pneumonia admitted from August 2011 to October 2014 were selected and divided into control group and observation group, with 54 cases in each group. Patients in the control group were treated by conventional method. On the basis of this, Ambroxol Hydrochloride and Procaterol Hydrochloride in combination therapy were given to compare the clinical efficacy of the two groups after treatment. Results: The total effective rate of the observation group after treatment was 94.44%, which was significantly higher than that of the control group (68.52%, P <0.05). Conclusion: Ambroxol hydrochloride combined with procaterol hydrochloride in children with pneumonia treatment is superior to the conventional treatment of clinical efficacy, and rapid relief of clinical symptoms and improve immune function.